A team of researchers at the University of Massachusetts Amherst has developed the first dual-color optoelectronic neural probe.

A novel PET imaging tracer has been proven to safely and effectively detect a common cancer gene mutation that is an important molecular marker for tumor-targeted therapy. By identifying this mutation early, physicians can tailor treatment plans for patients to achieve the best results. This research was published in the December issue of the Journal of Nuclear Medicine.

Because it was not possible to remove a hard-to-reach bulge in the central lymphatic system, a team of doctors from the Department of Plastic Surgery and Hand Surgery at the University Hospital Zurich (USZ) created a new drain to relieve the patient’s agonizing lymph congestion. For the first time, a microsurgical operating system was used for such a procedure.

ALWAY, Ireland–(BUSINESS WIRE)– Perfuze, a private medical device company dedicated to developing pioneering technology to treat acute ischemic stroke, proudly announces FDA clearance for the Millipede 070 Aspiration Catheter and the 2nd generation of the Millipede 088 Access Catheter.

Pulse Biosciences (Nasdaq:PLSE) today announced the

A team of UC Davis researchers led by bioengineer Aijun Wang has designed and tested a supportive structure, called a scaffold, that can help large deep burn wounds heal faster. The promising new treatment was found to promote the formation of new blood vessels and reduce complications linked to open burn wounds. It may also reduce the need for skin grafting in patients with significant burns over their body.

MINNEAPOLIS, Dec. 19, 2023 /PRNewswire/ — ShiraTronics, Inc., a trailblazing clinical-stage medical device company, today announced a landmark achievement with the successful implantation of its Chronic Migraine System in the world’s first six patients. This remarkable milestone represents a significant leap forward in neuromodulation, as the company unveils the first-ever fully implantable system for head location utilizing a minimally invasive approach.

Zoll Medical Corp. said a cyberattack may have exposed protected health information of current and former employees, dependants and beneficiaries.